P/E at 60.55 vs Industry's 67.38: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount Amidst Sector Premiums

The current P/E of 60.55 for Apollo Hospitals Enterprise Ltd. stands approximately 10.2% below the hospital industry’s average P/E of 67.38. This discount suggests that the stock is trading at a more conservative valuation relative to its peers, despite its large-cap stature and strong market presence. Such a valuation gap may reflect market caution or a recalibration of growth expectations within the sector. The hospital industry itself is characterised by elevated valuations, driven by robust demand and structural growth, making this discount particularly noteworthy — previously rated Buy, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: Strong Long-Term Gains with Mixed Short-Term Signals

Examining returns reveals a compelling long-term story. Over the past decade, Apollo Hospitals Enterprise Ltd. has delivered a staggering 548.89% return, significantly outperforming the Sensex’s 170.42% over the same period. The three-year and five-year returns of 82.11% and 74.85% respectively also comfortably exceed the Sensex’s 17.55% and 34.05%, underscoring sustained outperformance.

In the more recent past, the stock’s one-year return of 14.76% contrasts sharply with the Sensex’s decline of 4.36%, reinforcing its resilience. Year-to-date, the stock has surged 25.10%, while the Sensex remains down 9.81%. However, the short-term momentum is less robust: the stock has declined 0.77% over the past week and 1.62% over the last month, though these figures remain broadly in line with sector and benchmark movements. The three-month return of 8.77% still outpaces the Sensex’s 3.50%, indicating that any recent weakness is relative rather than absolute — is this short-term softness a pause in momentum or a signal of deeper challenges?

Moving Average Configuration: Bullish Across All Key Indicators

The technical setup for Apollo Hospitals Enterprise Ltd. is notably positive. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a strong upward trend across both short and long-term horizons. This alignment suggests sustained buying interest and a healthy technical foundation, which supports the recent gains and may provide a cushion against volatility. The stock’s proximity to its 52-week high—just 4.95% away—further emphasises its relative strength within the sector.

Sector Context: Hospital Industry Shows Mixed Results

The hospital sector has experienced a mixed performance landscape recently, with some companies posting gains while others face headwinds from regulatory pressures and cost inflation. Apollo Hospitals Enterprise Ltd. stands out with its consistent outperformance relative to the sector average, particularly over longer timeframes. The stock’s ability to maintain a valuation discount despite strong returns may reflect investor caution about sector-wide challenges, but it also highlights the company’s relative stability and operational strength.

Rating Context: Previously Rated Buy, Now Reassessed

MarketsMOJO had previously assigned a Buy rating to Apollo Hospitals Enterprise Ltd.. The rating was updated on 25 Aug 2026, reflecting a reassessment of the company’s fundamentals, valuation, and technical outlook. The current Mojo Score stands at 84.0, indicating a strong overall profile. This reassessment takes into account the valuation discount relative to the industry, the robust long-term performance, and the positive moving average configuration — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: Data Reflects a Balanced Yet Positive Outlook

The data for Apollo Hospitals Enterprise Ltd. presents a nuanced picture. The stock trades at a meaningful discount to its sector’s P/E ratio, despite delivering superior long-term returns and maintaining a strong technical position above all key moving averages. Short-term performance shows some softness but remains resilient relative to the broader market. The sector’s mixed results add context to the valuation gap, suggesting that investors are weighing both opportunities and risks carefully. The recent rating reassessment, following a previous Buy, reflects these complexities — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today